Disease Index
9,486 diseasesneurofibromatosis type II
type of neurofibromatosis disease
ICD: D33MeSH: D016518
neurofibromatosis-Noonan syndrome
human disease
MeSH: C537393
neurogenic arthrogryposis multiplex congenita
congenital joint contracture in two or more areas of the body
MeSH: C536614
neurogenic bladder
Human disease
ICD: N31.9MeSH: D001750
neurogenic palpebral tumor
human disease
neurogenic scapuloperoneal syndrome, Kaeser type
human disease
MeSH: C566695
neurogenic thoracic outlet syndrome
Neurogenic thoracic outlet syndrome (NTOS) is a form of thoracic outlet syndrome (TOS; see this term) that presents with pain, paresthesias and weakness in an upper extremity and is divided into true NTOS and disputed NTOS
neuroleptic malignant syndrome
nervous system disease that is characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness and is associated with administration of antipsychotic and other central dopaminergic blockers
ICD: G21.0MeSH: D009459
neurological disorder
disease of an anatomical entity located in the central or peripheral nervous system
MeSH: D009422
neurometabolic disease
human disease
neuromuscular disease
neuropathy that affect the nerves that control the voluntary muscles
MeSH: D009468
neuromuscular disease with dilated cardiomyopathy
human disease
neuromuscular junction disease
neuromuscular disease that is characterized by the disfunction of conduction through the neuromuscular junction
MeSH: D020511
neuromyelitis optica
inflammatory demyelinating diseases of the central nervous system characterized mainly by attacks of uni- or bilateral optic neuritis and acute myelitis
MeSH: D009471
Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory disorder of the central nervous system primarily affecting the optic nerves and spinal cord. Approximately 80% of patients have aquaporin-4 antibodies (AQP4-IgG). Clinical features include severe optic neuritis, longitudinally extensive transverse myelitis, and area postrema syndrome. Prevalence varies by ethnicity, ranging from 0.5 to 10 per 100,000, with higher rates in Asian and African populations.
ICD: G36.0MeSH: D009471
neuromyotonia
immune-mediated peripheral motor neuron disorder characterized by continuous muscle fiber activity at rest
ICD: G71.1MeSH: D020386
neuronal and mixed glio-neuronal tumor
Human disease
neuronal ceroid lipofuscinosis
human disease
MeSH: D009472
neuronal ceroid lipofuscinosis 1
human disease
neuronal ceroid lipofuscinosis 10
neuronal ceroid lipofuscinosis that has material basis in homozygous or compound heterozygous mutation in the CTSD gene on chromosome 11p15
neuronal ceroid lipofuscinosis 11
human disease
neuronal ceroid lipofuscinosis 13
human disease
neuronal ceroid lipofuscinosis 2
condition associated with mutation(s) in the TPP1 gene, encoding tripeptidyl-peptidase- 1. The condition is one of a group of genetically heterogeneous neurodegenerative disorders, characterized by accumulation of intracellular lipopigments
neuronal ceroid lipofuscinosis 3
condition associated with mutation(s) in the CLN3 gene, encoding battenin. The condition is one of a group of genetically heterogeneous neurodegenerative disorders, characterized by accumulation of intracellular lipopigments
neuronal ceroid lipofuscinosis 4A
human disease
neuronal ceroid lipofuscinosis 4B
human disease
neuronal ceroid lipofuscinosis 5
human disease
MeSH: C575534
neuronal ceroid lipofuscinosis 6
human disease
MeSH: C566627
neuronal ceroid lipofuscinosis 7
human disease
MeSH: C563989
neuronal ceroid lipofuscinosis 8
human disease